A tribute to Professor Yong Zhao

References

[1] Ge Y, Wu S, Zhang Z, Li X, Li F, Yan S, Liu H, Huang J, Zhao Y (2019) Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers. Protein Cell 10: 808- 824

[2] Mao P, Liu J, Zhang Z, Zhang H, Liu H, Gao S, Rong YS, Zhao Y (2016) Homologous recombination-dependent repair of telomeric DSBs in proliferating human cells. Nat Commun 7: 12154

[3] Xie C, Chen Y, Luo D, Zhuang Z, Jin H, Zhou H, Li X, Lin H, Zheng X, Zhang J et al (2021) Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7. Signal Transduct Target Ther 6: 84

[4] Zhao Y, Kan ZY, Zeng ZX, Hao YH, Chen H, Tan Z (2004) Determining the folding and unfolding rate constants of nucleic acids by biosensor. Application to telomere G-quadruplex. J Am Chem Soc 126: 13255- 13264

[5] Zhao Y, Hoshiyama H, Shay JW, Wright WE (2008) Quantitative telomeric overhang determination using a double-strand specific nuclease. Nucleic Acids Res 36: e14

[6] Zhao Y, Sfeir AJ, Zou Y, Buseman CM, Chow TT, Shay JW, Wright WE (2009) Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 138: 463- 475

[7] Zhao Y, Abreu E, Kim J, Stadler G, Eskiocak U, Terns MP, Terns RM, Shay JW, Wright WE (2011) Processive and distributive extension of human telomeres by telomerase under homeostatic and nonequilibrium conditions. Mol Cell 42: 297- 307

RIGHTS & PERMISSIONS

2021 The Author(s)